Furthermore, NLRP6 is downregulated during NASH and alcoholic hepatitis, thus increasing the pro-inflammatory and profibrotic effects of NF-κB, promoting fibrosis, and increasing the severity of the diseases82,83. Here, NLRP6 is linked to metabolic dysfunction-associated steatohepatitis.